Efficacy evaluation of digestive in patients who underwent gastrectomy for gastric cancer
- Conditions
- Neoplasms
- Registration Number
- KCT0008756
- Lead Sponsor
- ational Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 240
1. Patients 19 years of age or older
2. Patients who underwent gastrectomy for gastric cancer
3. Patients who do not need adjuvant chemotherapy and under follow- up
4. Patient having no abnormal finding in endoscopic examination at 3 months (±4 weeks), postoperatively
5. Patients having postprandial satiety or early satiety for more than 3 days per week at 3 months (±4 weeks) after surgery (postprandial distress syndrome of ROMA IV classification, postprandial distress syndrome
1. Vulnerable subjects (pregnant patients, those lacking communication ability, etc.)
2. Patients who have taken drugs classified as digestive agents within 7 days from the time of registration
3. Patients taking drugs that affect digestive function an evaluation (anti-cancer drugs, adrenal cortical hormone drugs, anti-inflammatory drugs, etc.)
4. Patients with genetic problems of galactose intolerance
5. Patients judged unsuitable for participation in this study by the researcher
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method symptom relief rate
- Secondary Outcome Measures
Name Time Method quality of life, compliance, adverse effect